← SEC 公告列表 | SIGA SEC 公告 | SIGA TECHNOLOGIES INC(SIGA)

重大事件 即時報告 8-K 2026-06-10

SIGA Technologies提交8-K報告 披露人事變動及股東投票結果

於 SEC 網站開啟原文

AI 繁中摘要

SIGA Technologies(股票代碼:SIGA)昨日(2026年6月10日)向美國證交會提交了8-K即時報告,報告日期為2026年6月9日。是次申報涉及三項主要事項: - 董事或高級職員離職、選舉、任命及相關薪酬安排(Item 5.02) - 股東投票事項結果(Item 5.07) - 財務報表及附件(Item 9.01) 公司總部位於紐約,主要從事藥物製劑業務(SIC 2834)。雖然8-K文件未披露具體財務數字或管理層展望,但人事變動與股東投票結果通常會影響公司治理及未來戰略方向。投資者應密切留意後續發布的詳細條款及過渡安排,以評估對管理層穩定性及股東權益的潛在影響。📄
展開英文正文
EDGAR Filing Documents for 0001140361-26-024780

 
 
 
 
 
 
 

 
 
 SEC.gov
 
 

 
 EDGAR
 

 

 
 
 Latest Filings 
 

 
 Filings search tools
 

 
 
 Filing Detail

 
 SEC Home »

 Company Search »

 Current Page

 

 
 
 Form 8-K - Current report: 
 

 
 SEC Accession No. 0001140361-26-024780
 

 

 
 
 
 Filing Date

 2026-06-10

 Accepted

 2026-06-10 16:05:24

 Documents

 12

 

 
 Period of Report

 2026-06-09

 

 
 Items

 Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

 

 

 
  Interactive Data
 

 

 

 
 Document Format Files

 
 
 Seq
 Description
 Document
 Type
 Size
 

 
 1
 8-K
 ef20075854_8k.htm   iXBRL
 8-K
 51232
 

 
 2
 EXHIBIT 10.1
 ef20075854_ex10-1.htm
 EX-10.1
 118553
 

 
  
 Complete submission text file
 0001140361-26-024780.txt
  
 326534
 

 
 

 
 Data Files

 
 
 Seq
 Description
 Document
 Type
 Size
 

 
 3
 XBRL TAXONOMY EXTENSION SCHEMA
 siga-20260609.xsd
 EX-101.SCH
 3853
 

 
 4
 XBRL TAXONOMY EXTENSION LABEL LINKBASE
 siga-20260609_lab.xml
 EX-101.LAB
 21966
 

 
 5
 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
 siga-20260609_pre.xml
 EX-101.PRE
 16036
 

 
 15
 EXTRACTED XBRL INSTANCE DOCUMENT
 ef20075854_8k_htm.xml
 XML
 4052
 

 
 

 Mailing Address
 31 EAST 62ND STREET
 
NEW YORK NY
10065 
 

 Business Address
 31 EAST 62ND STREET
 
NEW YORK NY
10065 
 212-672-9100
 

 SIGA TECHNOLOGIES INC (Filer)
 CIK: 0001010086 (see all company filings)
EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38436 | Film No.: 261079651
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)